The bone contrast on chest radiographs obtaind with computed radiography (CR, hereafter) is not decreased enough compaired with that for screen/film combination, even if we use a high tube voltage. This may be because the Exporsure Data Recognizer which can normalize the density and contrast of the chest images is performed. In order to increase the diagnostic accuracy for the lung disease,we propose to use a copper additional filter to decrease the bone contrast. Consequently, in order to have satisfied the bone contrast and the patient expousure dose, additional 0.3 mm copper filter and effective energy was 59.3 keV or more were required of the tube voltage of 140kV. Further, the effective energy of 140 kV tube voltage with a 0.7 mm copper, which is the maximum thickness of the additional filter within 50 m seconds in exporsure time, was 68 keV. Concluding these results, optimum range of additional copper filter is from 0.3 mm to 0.7 mm in chest high voltage radiography using CR. The bone contrast decreases sufficiently, if we use X-rays which have effective energy within this range. Our method is also useful to reduce patient dose.

Download full-text PDF

Source

Publication Analysis

Top Keywords

bone contrast
16
copper filter
12
tube voltage
12
effective energy
12
filter chest
8
contrast chest
8
additional filter
8
additional copper
8
copper
5
filter
5

Similar Publications

To directly examine the interplay between mutant p53 or Mdm2 and wild type p53 in gene occupancy and expression, an integrated RNA-seq and ChIP-seq analysis was performed in vivo using isogenically matched mouse strains. Response to radiation was used as an endpoint to place findings in a biologically relevant context. Unexpectedly, mutant p53 and Mdm2 only inhibit a subset of wild type p53-mediated gene expression.

View Article and Find Full Text PDF

A patient in his early adolescence, who was treated for T5-T6 tubercular spondylodiscitis with an un-instrumented decompression, presented at 36 months post-index surgery, for post-laminectomy instability and kyphosis, after completing his requisite antitubercular treatment. He underwent thoracic posterior instrumented kyphosis correction and anterior reconstruction, with a T5-T6 partial corpectomy and corpectomy spacer placement, through a posterior midline incision. On the second postoperative day, he started complaining of pain on the left side of his chest, abdomen and left shoulder.

View Article and Find Full Text PDF

Case: A 34-year-old man presented at our hospital with knee collapse. Magnetic resonance imaging (MRI) revealed posterior compression of the dural sac by a lumbar epidural lesion; however, a diagnosis could not be reached. Gadolinium (Gd)-enhanced 3-dimensional MRI (3D-MRI) clearly delineated the morphology, enabling us to make a preoperative diagnosis of posterior epidural migration of the lumbar disc fragment (PEMLDF).

View Article and Find Full Text PDF

Background: Spring-assisted surgery (SAS) and cranial vault remodeling (CVR) are widely used surgical techniques to correct sagittal craniosynostosis (SC). The authors evaluated changes in regional morphology of patients with SC who had undergone SAS or CVR, using the frontal bossing index (FBI), occipital bulleting index, vertex narrowing index (VNI), and scaphocephalic severity index (SCI) to capture differences in anterior protrusion, posterior protrusion, width restriction, and global dysmorphology, respectively.

Methods: Indices were measured on computed tomography and 3-dimensional photographs (n = 788) of 257 patients with SC from 2001 through 2022 who underwent SAS (n = 177) or CVR (n = 80).

View Article and Find Full Text PDF

Background And Aims: An expansion of fat mass is an integral feature of patients with heart failure and preserved ejection fraction (HFpEF). While body mass index (BMI) is the most common anthropometric measure, a measure of central adiposity-the waist-to-height ratio (WHtR)-focuses on body fat content and distribution; is not distorted by bone or muscle mass, sex, or ethnicity; and may be particularly relevant in HFpEF.

Methods: The PARAGON-HF trial randomized 4796 patients with heart failure and ejection fraction ≥45% to valsartan or sacubitril/valsartan.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!